Are eosinophils out of asthma?

Trends in Pharmacological Sciences

Volumn 22, Issue 2, 2001, Pages 61-62

  Giembycz, Mark ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; INTERLEUKIN 5; MEPOLIZUMAB; MONOCLONAL ANTIBODY; SCH 55700; UNCLASSIFIED DRUG;

APOPTOSIS; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EOSINOPHIL; HUMAN; MALE; NOTE; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0035252092     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01626-6     Document Type: Short Survey

References (2)

1. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
2. Results of a Phase I trial with SCH55700, a humanized anti-IL-5 antibody, in severe persistent asthma